Insulin-like growth factors and insulin: comparative aspects

Diabetologia

Volumn 28, Issue 8, 1985, Pages 485-493

  Froesch, E R ^a   Zapf, J ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; RADIOISOTOPE; SOMATOMEDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CHICKEN; DRUG COMPARISON; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DWARFISM; EMBRYO; ENDOCRINE SYSTEM; HISTOLOGY; HYPOGLYCEMIA; MOUSE; NONHUMAN; NUTRITION; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

ANIMAL; COMPARATIVE STUDY; HUMAN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; RECEPTOR, INSULIN; SOMATOMEDINS; SUPPORT, NON-U.S. GOV'T;

EID: 0021873617     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00281982     Document Type: Article

References (59)

1. The internal secretion of the pancreas
2. The amide groups of insulin
3. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro
4. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin
5. Primary structure of human insulin-like growth factor II
6. Sequence analysis of somatomedin C: Confirmation of identity with insulin-like growth factor I
7. The characterization of somatomedin A, isolated by microcomputer-controlled chromatography, reveals an apparent identity to insulin-like growth factor I
8. From NSILA to IGF: A look back on the major advances and breakthroughs
9. Insulin-like growth factors: A model for tertiary structure accounting for immunoreactivity and receptor binding
10. Insulin-like growth factors I and II: Some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulinlike activity of human serum
11. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins
12. Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor
13. Localization of insulin-like growth factor genes to human chromosomes 11 and 12
14. Human c-Ki-ras2 proto oncogene on chromosome 12
15. Dispersion of the ras family of transforming genes to four different chromosomes in man
16. Oncogene from human EJ bladder carcinoma is located on the short arm of chromosome 11
17. Sequence of C-DNA encoding human insulin-like growth factor I precursor
18. Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II
19. Demonstration of two subtypes of insulin-like growth factor receptors by affinity crosslinking
20. Receptor mediated phosphorylation of the hepatic insulin receptor: evidence that the 95 K receptor subunit is its own kinase
21. Microtubules, microfilaments and insulin secretion
22. Regulation of insulin release by calcium
23. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: Dependence on growth hormone status
24. Somatomedin synthesis by a subclone of Buffalo rat liver cells: Characterization and evidence for immediate secretion of de novo synthesized hormone
25. The insulin-like growth factors (IGF) of human serum: Chemical and biological characterization and aspects of their possible physiological role
26. Action of growth factors on chondrocytes: Discovery of local somatomedins in fetal bovine cartilage
27. Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture
28. Binding of nonsuppressible insulin-like activity to human serum: Evidence for a carrier protein
29. Demonstration of a specific serum carrier protein of nonsuppressible insulinlike activity in vivo
30. Specific binding of a somatomedin-like polypeptide in rat serum depends on growth hormone
31. Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin-like growth factors. Further evidence for the action of insulin-like growth factors through the insulin receptor
32. Binding of non-suppressible insulin-like activity to human serum: evidence for a carrier protein
33. Nonsuppressible insulin-like activity and sulfation activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs
34. Growth hormone dependence of nonsuppressible insulin-like activity (NSILA) and of NSILA-carrier protein
35. Nonsuppressible insulin-like activity of human serum. II Biological properties of plasma extracts with non-suppressible insulinlike activity
36. Nonsuppressible insulin-like activity (NSILA) of human serum. V. Hypoglycemia and preferential metabolic stimulation of muscle by NSILA-S
37. Effects of insulin and of NSILA on the perfused rat heart: Glucose uptake, lactate production and efflux of 3-O-methylglucose
38. Effects and binding on insulin-like growth factor I (IGFI) in the isolated soleus muscle of lean and obese mice: comparison with insulin
39. Fibroblasts as an experimental tool in metabolic and hormone studies. II. Effects of insulin and nonsuppressible insulin-like activity (NSILA-S) on fibroblasts in culture
40. Insulin-like growth factor I supports differentiation of cultured osteoblast-like cells
41. Effect of insulin-like growth factor on collagen and glycosaminoglycan synthesis by rabbit articular chondrocytes in culture
42. Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF I and IGF II) in primary cultures of chicken embryonic cells
43. Insulin-like growth factors stimulate synthesis of nucleic acids and glycogen in cultured calvaria cells
44. A new candidate for the regulation of erythropoiesis
45. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders
46. Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy
47. Insulin-like growth factor I and growth hormone in canine starvation
48. Insulin-like growth factor I stimulates growth in hypophysectomized rats
49. Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats
50. Dwarfism in the pygmy: An isolated deficiency of insulin-like growth factor I
51. Biological and immunological properties of insulin-like growth factors (IGF) I and II
52. Insulin-like growth factor I in the dog: a study in different dog breeds and in dogs with growth hormone elevation
53. Body size parallels insulin-like growth factor I levels but not growth hormone secretory capacity
54. Radioimmunological determination of insulin-like growth factor I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia
55. The physiology and pharmacology of adipose tissue lipolysis: its inhibition and implications for the treatment of diabetes
56. Carbohydrate metabolism and lipid storage and breakdown in diabetes
57. Somatomedin receptors in the human brain throughout life
58. Evidence for two species of insulin-like growth factor II (IGF II and “big” IGF II) in human spinal fluid